Can an adult patient with a history of substance use disorder smoke seeds while taking naltrexone (opioid receptor antagonist)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cannabis Use While Taking Naltrexone

Yes, a patient can smoke cannabis (seeds/marijuana) while taking naltrexone, as there are no absolute contraindications to this combination, though naltrexone may actually reduce cannabis use and its subjective effects.

Pharmacological Interaction and Safety Profile

Naltrexone does not create dangerous drug interactions with cannabis. The primary mechanism of naltrexone is mu-opioid receptor antagonism, which does not directly interfere with cannabis's action on cannabinoid receptors 1. There are no documented safety concerns regarding cardiovascular effects, seizure risk, or other serious adverse events from combining these substances.

Key Safety Considerations for Naltrexone Use

The actual contraindications for naltrexone therapy are distinct from cannabis use:

  • Current opioid use is the absolute contraindication - naltrexone will precipitate severe withdrawal in opioid-dependent patients and block pain relief from opioid medications 1, 2, 3
  • Liver function monitoring is required - baseline and every 3-6 months, as naltrexone has been associated with hepatic injury at supratherapeutic doses 1, 3
  • Uncontrolled hypertension is a contraindication when naltrexone is combined with bupropion (as in naltrexone-bupropion ER formulations), but not for naltrexone monotherapy 2, 3

Potential Therapeutic Effect on Cannabis Use

Emerging evidence suggests naltrexone may actually reduce cannabis consumption rather than being contraindicated with it:

  • A double-blind, placebo-controlled study demonstrated that naltrexone maintenance (50 mg daily) significantly reduced both active cannabis self-administration and positive subjective effects in daily cannabis smokers 4
  • Participants receiving naltrexone had 7.6 times lower odds of self-administering active cannabis compared to placebo (95% CI: 1.1-51.8) 4
  • This reduction in reinforcing effects extended to cannabis use in natural settings outside the laboratory 4

Clinical Implications

For patients with substance use disorder taking naltrexone who also use cannabis:

  • Cannabis use does not require discontinuation of naltrexone therapy - there are no safety concerns that would mandate stopping the medication 4
  • Naltrexone may provide an additional benefit by reducing cannabis consumption and craving, though this is not its primary indication 4
  • Monitor for naltrexone's intrinsic side effects including decreased appetite, gastrointestinal upset, and headache, which are unrelated to cannabis use 4

Important Caveats

The critical distinction is between naltrexone monotherapy versus naltrexone-bupropion combination products:

  • Naltrexone-bupropion ER has additional contraindications related to the bupropion component, including seizure disorders and abrupt benzodiazepine discontinuation 2, 3
  • These bupropion-related contraindications do not apply to naltrexone monotherapy 1, 5
  • Cannabis use itself does not interact with either formulation from a safety standpoint 4

Ensure the patient is not using opioids concurrently, as this remains the primary contraindication regardless of cannabis use 1, 2, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Naltrexone-Bupropion Combination Therapy with Phentermine, Lorazepam, and Ambien

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Naltrexone and Lorazepam Combination Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015

Research

Naltrexone: its clinical utility.

Advances in alcohol & substance abuse, 1985

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.